Category Archives: People

BRISBANE, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its second quarter 2026 financial results after the close of the U.S. markets on Tuesday August 4, 2026. […]

SANTA CRUZ, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced the appointment of Neera Ravindran, M.D., M.B.A., as chief financial officer. Dr. Ravindran brings more than 20 years of deep public markets and private company experience, with a demonstrated […]

WILMETTE, Ill., July 22, 2026 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that it has initiated the rolling submission of a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for ALXN1840 […]

SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental application for toripalimab in combination with platinum-containing chemotherapy as perioperative treatment and subsequent monotherapy as adjuvant therapy for […]

WASHINGTON, July 21, 2026 (GLOBE NEWSWIRE) — The Coalition to Improve Access to Cancer Care (CIACC), convened by the International Myeloma Foundation (IMF), applauds Senators Tina Smith (D-MN) and Jerry Moran (R-KS) for reintroducing the bipartisan Cancer Drug Parity Act, legislation that would ensure patients do not face higher out of pocket costs simply because […]

BOCA RATON, Fla., July 21, 2026 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second quarter ended June 30, 2026, after the market closes on Tuesday, July 28, 2026. Management will host […]

Peer-reviewed publication of ProstACT SELECT1 results confirm the utility of 68Ga (gallium)-PSMA-PET imaging to select patients for TLX591-Tx therapy using a theranostic approach2. Consistent with previously reported results3, the publication highlights TLX591-Tx’s clinical differentiation and safety profile. TLX591-Tx, Telix’s lead PSMA-targeting rADC therapy candidate, is currently being evaluated in ProstACT Global Phase 3 study4 for […]

WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has commenced an underwritten public offering of $300,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a […]

The Miami-founded luxury surfaces distributor curates the top tier of global stone for designers and architects across three South Florida showrooms Miami, July 21, 2026 (GLOBE NEWSWIRE) — KEY POINTS Curates top-tier global stone rather than stocking broad commodity inventory. Operates three South Florida showrooms with full slabs on display: Miami, Fort Lauderdale and West […]

Physician-led partnership establishes BBP’s first presence in the Midwest, adding a 17-location behavioral health platform, creating a foundation for continued national growth PLANO, Texas, July 21, 2026 (GLOBE NEWSWIRE) — Beacon Behavioral Partners (BBP), a growing network of independent psychiatric practices, today announced its partnership with Pure Psychiatry, establishing the company’s first presence in Michigan […]